530 related articles for article (PubMed ID: 21093334)
1. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
[TBL] [Abstract][Full Text] [Related]
3. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
4. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
6. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
7. Effects of short term growth hormone therapy in adult growth hormone deficiency.
Dutta P; Bhansali A; Ajith Kumar BV; Sharma R; Jaggi S; Bhadada S
J Assoc Physicians India; 2010 Nov; 58():670-3. PubMed ID: 21510459
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
9. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
[TBL] [Abstract][Full Text] [Related]
11. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
[TBL] [Abstract][Full Text] [Related]
12. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
Lamberts SW
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
[TBL] [Abstract][Full Text] [Related]
13. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
[TBL] [Abstract][Full Text] [Related]
14. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
15. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
16. Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database).
Gutiérrez LP; Kołtowska-Häggström M; Jönsson PJ; Mattsson AF; Svensson D; Westberg B; Luger A
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):90-102. PubMed ID: 17957812
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency.
Schneider HJ; Klotsche J; Wittchen HU; Stalla GK; Schopohl J; Kann PH; Kreitschmann-Andermahr I; Wallaschofski H;
Clin Endocrinol (Oxf); 2011 Dec; 75(6):825-30. PubMed ID: 21658091
[TBL] [Abstract][Full Text] [Related]
18. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.
Moock J; Albrecht C; Friedrich N; Völzke H; Nauck M; Koltowska-Haggström M; Kohlmann T; Wallaschofski H
Eur J Endocrinol; 2009 Jan; 160(1):17-24. PubMed ID: 18974232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
